Terns Pharmaceuticals Competitors and Similar CompaniesClear all
Novartis's competitors and similar companies include Rigel Pharmaceuticals and Ncardia.
 Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. | ||
Founding Date | Founding Date 1996 | Founding Date 1996 | Founding Date 2010 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations South San Francisco, US HQ | Locations Gosselies, BE HQ Leiden, NL |
Employees | Employees 75,883 | Employees 1633% increase | Employees 547% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $294.3m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $8.4b (FY, 2025) | Cost of goods $19.6m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $49.8b (FY, 2025) | Gross profit $274.7m (FY, 2025) | Gross profit N/A |
Net income | Net income $14b (FY, 2025) | Net income $367m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 6.5m | Total funding raised $ 130m | Total funding raised $ 20.2m |
For sources of this data, please see the company profile
View Company Profiles
Rigel Pharmaceuticals
HQ
South San Francisco, US
Employees
163↑ 3% increase
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
View company
Ncardia
HQ
Gosselies, BE
Employees
54↓ 7% decrease
Ncardia is a stem cell drug discovery and development company.
View company